Our Team
Board of Directors
LAUREN LEIMAN
Executive Director, BLOODPAC Consortium
PHILLIP G. FEBBO, MD
Chief Scientific Officer & Chief Medical Officer, Veracyte
PETER KUHN, PhD
Professor, University of Southern California
LUCA QUAGLIATA, PhD
Corporate Head of Diagnostic Medical and Scientific Affairs, Products and Technology Sector, Thermo Fisher Scientific
ROBERT LOBERG, PhD
Vice President, Life Cycle Leader - Oncology & Genetics, Roche
JAKE VINSON
Chief Executive Officer, Prostate Cancer Clinical Trials Consortium
Scientific Advisory Committee
JIM GODSEY, PhD
Scientific Co-Chair, BLOODPAC
ROBERT L. GROSSMAN, PhD
Professor, University of Chicago CTDS & Founder/Director, Open Commons Consortium
JERRY LEE, PhD
Chief Science and Innovation Officer, Ellison Institute of Technology
Scientific Co-Chair Committee
JONATHAN BADEN
Executive Director & Head of Precision Medicine, Bristol Myers Squibb
KELLI BRAMLETT
Committee Chair
Executive Director of Molecular Oncology, Quest Diagnostics
DARYA CHUDOVA, PhD
Chief Technology Officer, Guardant Health
JENNIFER DICKEY, PhD
Head of Regulatory and Quality, Labcorp
ELIZABETH MANSFIELD, PhD
Vice President of Regulatory Policy, Foundation Medicine
TRACI PAWLOWSKI, PhD
Vice President of R&D, NeoGenomics
ANGELA SILVESTRO
Director of Companion Diagnostics, GSK
JOHN SIMMONS
Global Vice President of Biopharma & Oncology Partnerships, Natera
BLOODPAC Team
BRIAN MINIE
Director of Data Science, BLOODPAC
CHEYENNE JANKIEWICZ
Program Manager / Data Coordinator, BLOODPAC
DORYS LOPEZ, PhD
Head of Scientific Communications, BLOODPAC
GINGER RIESSEN, CPA
Accountant, BLOODPAC